GeoVax Labs, Inc. New

GOVXNASDAQ • USD
ThemeBiotech - Drug Development›Infectious Disease & Vaccines
0.29 USD
↘ 0.03 (9.82%)AT CLOSE (03:59 PM EDT)
0.28
↘ 0.01 (2.95%)
POST MARKET (AS OF 06:22 PM EDT)
Post Market
AS OF 06:22 PM EDT
0.28
↘ 0.01 (2.95%)
🟢Market: OPEN

GeoVax Labs, Inc. New (GOVX) trades at $0.28 per share. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Oct 6, 2026.

Open?$0.32
High?$0.33
Low?$0.28
Prev. Close?$0.32
Volume?1.6M
Avg. Volume?889.2K
VWAP?$0.30
Rel. Volume?1.84x
Bid / Ask
Bid?$0.25 × 100
Ask?$0.35 × 100
Spread?$0.11
Midpoint?$0.30
Valuation & Ratios
Market Cap?2.9M
Shares Out?10.1M
Float?9.1M
Float %?99.8%
P/E Ratio?N/A
P/B Ratio?1.65
EPS?-$2.25
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. The company is focused on the advancement of GEO-MVA, a Modified Vaccinia Ankara (MVA) vaccine candidate for mpox, smallpox, and other poxviruses. Its flagship clinical program in oncology is Gedeptin, a novel oncolytic solid tumor gene-directed therapy, which recently completed a multicenter Phase 1/2 clinical trial for head and neck cancers. The company is also developing GEO-CM04S1, a next-generation multi-antigen COVID-19 vaccine, which is currently being evaluated in two Phase 2 clinical trials.
Themes
Biotech - Drug Development›Infectious Disease & VaccinesHealthcare - Oncology›Immunotherapy & Immuno-Oncology
Employees
19
Market Cap
2.9M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.geovax.com
Listed
1995-02-01
Address
1955 LAKE PARK DRIVE
SMYRNA, GA
Phone: 678-384-7220
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
65
Short Sent.?
51
Piotroski F-Score?0/9Weak
Altman Z-Score?-62.01Distress
Confidence?49%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?5.49%Elevated
Short Interest?498.7K
Days to Cover?1.4
Free Float9.1M
Avg Daily Volume357.7K
Settlement Date2026-09-15
Financial Health
Current Ratio?1.54Adequate
Quick Ratio?1.54Adequate
Cash Ratio?1.16Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
83
1.65CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
0.0CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-1,160.1%WEAK▾
ROA?
S&P
3
-440.0%WEAK▾
Cash Flow & Enterprise
FCF?$-18369715
Enterprise Value?$-233383
Fundamentals ratios updated end of day
MarketsMoversWatchlist